SCHEMBL4585503

SCHEMBL4585503

CC(C)n1cc(-c2ncc(N)nc2-c2cccs2)ccc1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 4/20 0.65
ADORA1 P30542 2/20 0.65
BMPR1B O00238 3/20 0.43
BMPR1A P36894 3/20 0.43
TGFBR1 P36897 3/20 0.43
ACVRL1 P37023 3/20 0.43
ACVR1 Q04771 3/20 0.43
ATR Q13535 9/20 0.39
KDM5B Q9UGL1 1/20 0.38
MEN1 O00255 2/20 0.37
USP2 O75604 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CASP1 P29466 2/20 0.37
CASP7 P55210 2/20 0.37
KMT2A Q03164 2/20 0.37
HIF1A Q16665 2/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP2C9 P11712 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4584602 0.87 ADORA2A (0.48) ADORA2AADORA1KDM5BMEN1USP2
SCHEMBL4586085 0.83 ADORA2A (0.79) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4586548 0.82 ADORA2A (0.67) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4584666 0.81 ADORA2A (0.77) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4584342 0.81 ADORA2A (0.69) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4585018 0.80 ADORA2A (0.45) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4585715 0.80 ADORA2A (0.45) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4584515 0.80 ADORA2A (0.64) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL4584024 0.79 ADORA2A (0.77) ADORA2AADORA1BMPR1BBMPR1ATGFBR1
SCHEMBL29443963 0.79 ADORA2A (1.00) ADORA2AADORA1BMPR1BBMPR1ATGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7407961-B2 Pyrazine derivatives and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2008-08-05 US disclosed
CN-1871231-A Pyrazine derivatives and pharmaceutical use thereof ASTELLAS PHARMA INC (JP) 2006-11-29 CN disclosed
US-20050113387-A1 Pyrazine derivatives and pharmaceutical use thereof FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113387-A1 Pyrazine derivatives and pharmaceutical use thereof ADORA2A, P2RX5, ADORA1 ADORA2A 1/4885ADORA1 3/4885BMPR1B 3464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.